Sophiris Bio Inc. (SPHS) Stock Price, Forecast & Analysis
USA - NASDAQ:SPHS -
SPHS Key Statistics, Chart & Performance
The current stock price of SPHS is 0.23 null. In the past month the price decreased by -65.86%. In the past year, price decreased by -78.5%.
SPHS Latest News, Press Relases and Analysis
About SPHS
Company Profile
Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.
Company Info
Sophiris Bio Inc.
1258 PROSPECT STREET
LA JOLLA CA 92037
CEO: Randall E. Woods
Phone: 858-777-1760
Sophiris Bio Inc. / SPHS FAQ
What does SPHS do?
Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.
What is the current price of SPHS stock?
The current stock price of SPHS is 0.23 null. The price decreased by -60.3% in the last trading session.
What is the dividend status of Sophiris Bio Inc.?
SPHS does not pay a dividend.
What is the ChartMill rating of Sophiris Bio Inc. stock?
SPHS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for SPHS stock?
Sophiris Bio Inc. (SPHS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.33).
SPHS Technical Analysis
SPHS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SPHS. SPHS has a bad profitability rating. Also its financial health evaluation is rather negative.
SPHS Financial Highlights
Over the last trailing twelve months SPHS reported a non-GAAP Earnings per Share(EPS) of -0.33000000000000007. The EPS increased by 31.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 0.52% | ||
| ROE | N/A | ||
| Debt/Equity | -1.12 |